Background
The spread and emerging infections remains a serious public health threat. Infections account for considerable health care costs and lost duty days, about one-fourth of all physician visits involve an infection. The number of pathogens resistant to one or more previously effective antibiotics is also increasing rapidly, reducing treatment options and adding to the health care costs. Surveillance is the most important tool for detecting existing and emerging infections. Surveillance of antibiotics resistance is critical to monitoring changing patterns of resistance, providing early warning of public health threats and their potential impact on military healthcare and readiness, and targeting and evaluating prevention and control measures.
The EpiData Center developed methods for the use of CHCS-based data for surveillance and has years of expertise in use of these data for the surveillance of antibiotic resistance and emerging pathogens. This Navy Antimicrobial Surveillance System (NASS) allows for easier identification of emerging infectious organisms, rapid characterization of multi-drug resistance profiles, and supports the following products implemented across the U.S. Department of Navy and Department of Defense (DOD).
Multidrug-Resistant Organism Monthly Summary Report (DON)
- Monthly Reports April 2012
- Monthly Reports March 2012
- Monthly Reports February 2012
- Monthly Reports January 2012
MRSA (DOD)
Acinetobacter (DOD)
New Delhi metallo-β-lactamase 1 (NDM-1) Enterobacteriaceae (DOD)
-
Monthly Reports
-
SITREP Reports
Hospital Acquired Infection Surveillance
- Infection Burden Metrics
- Hospital Exposure Burden Metrics
Antibiotic Resistant Organism Dashboard
Monthly Reports
Quarterly Reports
Content last reviewed on May 9, 2012.





